Moolec Science (MLEC) Depreciation & Amortization (CF) (2023 - 2024)

Moolec Science's (MLEC) quarterly Depreciation & Amortization (CF) came in at -$48102.0 in Q4 2024, down 18.39% year-on-year from -$58939.5 in Q1 2024, and down 100.85% quarter-over-quarter from $5.7 million in Q2 2024.

Moolec Science (MLEC) Depreciation & Amortization (CF) (2023 - 2024) Analysis & Trends

Moolec Science has disclosed Depreciation & Amortization (CF) across 2 years of filings, most recently posting -$48102.0 for Q4 2024.

  • Depreciation & Amortization (CF) for Q4 2024 came in at -$48102.0, down 18.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$48102.0 (changed N/A YoY), and the FY2025 annual result was $6.0 million, up 3.72% from the prior year.
  • Depreciation & Amortization (CF) came in at -$48102.0 for Q4 2024 at Moolec Science, down from $5.7 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.7 million in Q2 2024 to a low of -$48102.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1,395.22
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 55.90 Mn
9 Abivax 94.26 Bn 94.26 Bn - 429,663.65
10 Moolec Science 6.98 Bn 6.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -48,102.00
Dec 31, 2024 -48,102.00
Jun 30, 2024 5.68 Mn
Jun 30, 2024 5.68 Mn
Mar 31, 2024 61,816.00
Mar 31, 2024 61,816.00
Dec 31, 2023 -40,631.00
Dec 31, 2023 -40,631.00
Jun 30, 2023 4.94 Mn
Jun 30, 2023 4.94 Mn
Mar 31, 2023 425.00
Mar 31, 2023 425.00